Acadia Pharma (ACAD) Tops Q3 EPS by 5c, Beats on Revenue, Offers Guidance
Go back to Acadia Pharma (ACAD) Tops Q3 EPS by 5c, Beats on Revenue, Offers Guidance| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 21.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.39 | 52 Week High | $42.49 | |||
| Open | $21.39 | 52 Week Low | $16.64 | |||
| Day High | $21.39 | P/E | N/A | |||
| Day Low | $21.39 | EPS | $-0.42 | |||
| Volume | 116 | |||||
